Acutus Medical, Inc.
Acutus Medical, Inc. (AFIB) Stock Overview
Explore Acutus Medical, Inc.’s financial performance, market position, analyst ratings, and future outlook.
AFIB Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Acutus Medical, Inc. (AFIB) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $0.02.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -0.01 and a market capitalization of 53.8K. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Company Profile
Acutus Medical, Inc., an arrhythmia management company, designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias in the United States and internationally. The company's product portfolio includes novel access sheaths, transseptal crossing tools, diagnostic and mapping catheters, conventional and contact force ablation catheters, and mapping and imaging consoles and accessories, as well as supporting algorithms and software programs. Acutus Medical, Inc. was incorporated in 2011 and is headquartered in Carlsbad, California.
Mr. Takeo Mukai
85
2210 Faraday Avenue, Carlsbad, CA
2020